← Back to Analyst Consensus 
TXG Hold
10x Genomics, Inc.
Current Price —
Implied Upside —
Analysts 22
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 6 reiterations from 7 firms
Next Earnings
Nov 5, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | maintain | Hold → Hold | — | 54% |
| Oct 13, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Oct 12, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Oct 7, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Sep 29, 2026 | Leerink Partners | maintain | Market Perform → Market Perform | — | 51% |
| Sep 28, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| Sep 28, 2026 | Argus Research | initiate | — → Buy | — | 54% |
| Sep 9, 2026 | UBS | maintain | Neutral → Neutral | — | 54% |
| Sep 1, 2026 | RBC Capital | initiate | — → Sector Perform | — | 55% |
| Aug 12, 2026 | Stephens & Co. | maintain | Overweight → Overweight | — | 54% |
| Aug 10, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| Aug 10, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Aug 7, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Aug 7, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 17, 2026 | Leerink Partners | maintain | Market Perform → Market Perform | — | 51% |
| Jul 14, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 9, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 8, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Jul 1, 2026 | Piper Sandler | maintain | Neutral → Neutral | — | 54% |
| Jun 24, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| May 12, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| May 12, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 55% |
| Apr 20, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Apr 20, 2026 | B of A Securities | maintain | Neutral → Neutral | — | 53% |
| Apr 14, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Apr 7, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Mar 31, 2026 | William Blair | upgrade | Market Perform → Outperform | — | 48% |
| Mar 2, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Feb 20, 2026 | UBS | maintain | Neutral → Neutral | $20 | 54% |
| Feb 13, 2026 | Stifel | maintain | Buy → Buy | $20 | 53% |
| Feb 13, 2026 | TD Cowen | maintain | Hold → Hold | $19 | 54% |
| Jan 27, 2026 | Leerink Partners | maintain | Market Perform → Market Perform | $20 | 51% |
| Jan 16, 2026 | Leerink Partners | maintain | Market Perform → Market Perform | $22 | 51% |
| Jan 7, 2026 | Leerink Partners | maintain | Market Perform → Market Perform | $20 | 51% |
| Jan 7, 2026 | TD Cowen | maintain | Hold → Hold | $18 | 54% |
| Dec 22, 2025 | Canaccord Genuity | maintain | Buy → Buy | $20 | 48% |
| Dec 15, 2025 | Barclays | maintain | Overweight → Overweight | $22 | 53% |
| Dec 11, 2025 | Citigroup | downgrade | Buy → Neutral | $18 | 54% |
| Dec 2, 2025 | Morgan Stanley | downgrade | Overweight → Equal-Weight | $20 | 54% |
| Nov 11, 2025 | Piper Sandler | maintain | Neutral → Neutral | $19 | 54% |
| Nov 7, 2025 | Canaccord Genuity | maintain | Buy → Buy | $19 | 48% |
| Nov 7, 2025 | JP Morgan | maintain | Neutral → Neutral | $15 | 55% |
| Nov 7, 2025 | UBS | maintain | Neutral → Neutral | $14 | 54% |
| Nov 7, 2025 | Barclays | maintain | Overweight → Overweight | $17 | 53% |
| Sep 11, 2025 | Piper Sandler | initiate | — → Neutral | $15 | 54% |
| Aug 12, 2025 | Morgan Stanley | maintain | Overweight → Overweight | $17 | 54% |
| Aug 8, 2025 | UBS | maintain | Neutral → Neutral | $13 | 54% |
| Aug 8, 2025 | Barclays | maintain | Overweight → Overweight | $15 | 53% |
| Jun 26, 2025 | B of A Securities | maintain | Neutral → Neutral | $13 | 53% |
| Jun 24, 2025 | Barclays | maintain | Overweight → Overweight | $13 | 53% |
Price Target Trend
Jun 8, 2026 Latest: $77.5 Oct 26, 2026
EPS Estimates
+1q $-0.01
Lo: $-0.06 Hi: $0.05
2 analysts ▲1
0y $0.04
Lo: $-0.10 Hi: $0.18
3 analysts ▲1
+1y $0.08
Lo: $0.01 Hi: $0.17
3 analysts ▲1
0q $-0.02
Lo: $-0.04 Hi: $0.00
2 analysts ▲2
Cross-Platform Signals
No cross-platform signals in the last 90 days